# OnCo record template-mapping-biopsy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/template-mapping-biopsy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "template-mapping-biopsy" ;
  schema:name "Template mapping biopsy (transperineal template prostate mapping)"@en ;
  schema:alternateName "transperineal template mapping biopsy"@en, "template prostate mapping"@en, "TPM biopsy"@en, "mapping template biopsy"@en, "transperineal template biopsy"@en, "5 mm template mapping biopsy"@en ;
  schema:description "A thorough biopsy done under general anaesthetic through the skin behind the scrotum, using a grid to sample the whole prostate systematically. It gives the most complete picture available short of removing the gland, and for that reason it is used as the yardstick in research rather than as a routine test."@en ;
  schema:url <https://onco.cc/terms/template-mapping-biopsy/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Prostate_biopsy> ;
  schema:citation <https://www.nice.org.uk/guidance/ng131/chapter/Terms-used-in-this-guideline>, <https://www.nice.org.uk/guidance/ng131/chapter/Recommendations>, <https://doi.org/10.1016/s0140-6736(16)32401-1> ;
  onco:tag "gu", "prostate-glossary" ;
  onco:related <https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/>, <https://onco.cc/key-papers/paper-precision-mri-targeted-biopsy-nejm-2018/>, <https://onco.cc/terms/pi-rads/>, <https://onco.cc/terms/whole-mount-pathology/>, <https://onco.cc/ideas/idea-prostate-per-lesion-mri-audit-before-focal-treatment/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/surgery/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/prostate-screening-psa-mri/> ;
  onco:terms <https://onco.cc/terms/pi-rads/>, <https://onco.cc/terms/whole-mount-pathology/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/acute-urinary-retention/>, <https://onco.cc/terms/psa/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/>, <https://onco.cc/key-papers/paper-johnson-mpmri-individual-foci-eur-urol-2019/> .